This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wagner, G. S. Articles by Selvester, R. H. Search for Related Content PubMed PubMed Citation Articles by Wagner, G. S. Articles by Selvester, R. H.

Circulation, Vol 65, 342-347, Copyright © 1982 by American Heart Association

ARTICLES

Evaluation of a QRS scoring system for estimating myocardial infarct size. I. Specificity and observer agreement

GS Wagner, CJ Freye, ST Palmeri, SF Roark, NC Stack, RE Ideker, FE Harrell Jr and RH Selvester

We evaluated a simplified version of a previously developed QRS scoring system for estimating infarct size using observations of Q- and R-wave durations and R/Q and R/S amplitude ratios in the standard 12-lead ECG. Groups of subjects with a minimal likelihood of having myocardial infarcts and minimal likelihood of having common noninfarction sources of QRS modification were studied to establish the specificity of each of the 37 criteria. Only two criteria required modification to achieve 95% specificity. These 37 criteria form the basis of a 29-point QRS scoring system. A 98% specificity was achieved when a score of more than 2 points was required to identify a myocardial infarct. Fifty patients were studied to determine the intra- and interobserver agreement with this scoring system. Each criterion achieved at least 91% intra- and interobserver agreement. These impressive levels of specificity and observer agreement must be matched by high sensitivity of the scoring system and a good correlation between the point score and infarct size in patients with proven infarcts if the point score is to be useful for detecting and sizing infarcts. Sensitivity and correlation between point score and infarct size are evaluated in later studies in this series. The standard ECG is inexpensive and can be obtained repetitively and noninvasively; its QRS complex may be an important means of estimating the size, presence and location of myocardial infarcts.

This article has been cited by other articles:

				T. Vartdal, H. Brunvand, E. Pettersen, H.-J. Smith, E. Lyseggen, T. Helle-Valle, H. Skulstad, H. Ihlen, and T. Edvardsen Early Prediction of Infarct Size by Strain Doppler Echocardiography After Coronary Reperfusion J. Am. Coll. Cardiol., April 24, 2007; 49(16): 1715 - 1721. [Abstract] [Full Text] [PDF]

				S. Savonitto, M. G. Cohen, A. Politi, M. P. Hudson, D. F. Kong, Y. Huang, K. S. Pieper, F. Mauri, G. S. Wagner, R. M. Califf, et al. Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes Eur. Heart J., October 2, 2005; 26(20): 2106 - 2113. [Abstract] [Full Text] [PDF]

				C. Vahlhaus, H.-J. Bruns, J. Stypmann, T. D.T Tjan, F. Janssen, M. Schafers, H. H Scheld, O. Schober, G. Breithardt, and T. Wichter Direct epicardial mapping predicts the recovery of left ventricular dysfunction in chronic ischaemic myocardium Eur. Heart J., January 2, 2004; 25(2): 151 - 157. [Abstract] [Full Text] [PDF]

				P. Porela, H. Helenius, K. Pulkki, and L.-M. Voipio-Pulkki Epidemiological classification of acute myocardial infarction: time for a change? Eur. Heart J., October 2, 1999; 20(20): 1459 - 1464. [Abstract] [PDF]

				P. Theroux, J. Gregoire, C. Chin, G. Pelletier, P. de Guise, and M. Juneau Intravenous diltiazem in acute myocardial infarction: Diltiazem as adjunctive therapy to activase (DATA) trial J. Am. Coll. Cardiol., September 1, 1998; 32(3): 620 - 628. [Abstract] [Full Text] [PDF]

				R. L. Murkofsky, G. Dangas, J. A. Diamond, D. Mehta, A. Schaffer, and J. A. Ambrose A prolonged QRS duration on surface electrocardiogram is a specific indicator of left ventricular dysfunction J. Am. Coll. Cardiol., August 1, 1998; 32(2): 476 - 482. [Abstract] [Full Text] [PDF]

				S. Ozgul and G. Z. Kudaiberdieva Silent Myocardial Ischemia After Myocardial Infarction: Severity of Coronary Artery Disease, Impact on Left Ventricular Systolic and Diastolic Functions and Prognosis Angiology, June 1, 1998; 49(6): 455 - 462. [Abstract] [PDF]

				M A Khan, S Sinha, S Hayton, S Fynn, R A Henderson, and D H Bennett A normal electrocardiogram precludes the need for left ventriculography in the assessment of coronary artery disease Heart, March 1, 1998; 79(3): 262 - 267. [Abstract] [Full Text]

				K. Ishikawa, S. Nakai, T. Takenaka, K. Kanamasa, J. Hama, I. Ogawa, T. Yamamoto, M. Oyaizu, A. Kimura, K. Yamamoto, et al. Short-Acting Nifedipine and Diltiazem Do Not Reduce the Incidence of Cardiac Events in Patients With Healed Myocardial Infarction Circulation, May 20, 1997; 95(10): 2368 - 2373. [Abstract] [Full Text]

				P. Lander, P. Gomis, R. Goyal, E. J. Berbari, P. Caminal, R. Lazzara, and J. S. Steinberg Analysis of Abnormal Intra-QRS Potentials : Improved Predictive Value for Arrhythmic Events With the Signal-Averaged Electrocardiogram Circulation, March 18, 1997; 95(6): 1386 - 1393. [Abstract] [Full Text]

				B. Takase, T. Maruyama, A. Kurita, A. Uehata, T. Nishioka, K. Mizuno, H. Nakamura, K. Katsura, and Y. Kanda Arachidonic Acid Metabolites in Acute Myocardial Infarction Angiology, July 1, 1996; 47(7): 649 - 661. [Abstract] [PDF]

				T. D. Miller, T. F. Christian, M. R. Hopfenspirger, D. O. Hodge, B. J. Gersh, and R. J. Gibbons Infarct Size After Acute Myocardial Infarction Measured by Quantitative Tomographic 99mTc Sestamibi Imaging Predicts Subsequent Mortality Circulation, August 1, 1995; 92(3): 334 - 341. [Abstract] [Full Text]

				A. A. Maggioni, A. Maseri, C. Fresco, M. G. Franzosi, F. Mauri, E. Santoro, G. Tognoni, and The Investigators of the Gruppo Italiano por lo St Age-Related Increase in Mortality among Patients with First Myocardial Infarctions Treated with Thrombolysis N. Engl. J. Med., November 11, 1993; 329(20): 1442 - 1448. [Abstract] [Full Text]